Cargando…
Itolizumab – a humanized anti-CD6 monoclonal antibody with better side effects profile for the treatment of psoriasis [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461136/ https://www.ncbi.nlm.nih.gov/pubmed/26082656 http://dx.doi.org/10.2147/CCID.S88448 |
_version_ | 1782375488269844480 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4461136 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-44611362015-06-16 Itolizumab – a humanized anti-CD6 monoclonal antibody with better side effects profile for the treatment of psoriasis [Corrigendum] Clin Cosmet Investig Dermatol Corrigendum Dove Medical Press 2015-06-05 /pmc/articles/PMC4461136/ /pubmed/26082656 http://dx.doi.org/10.2147/CCID.S88448 Text en © 2015 Menon and David. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Corrigendum Itolizumab – a humanized anti-CD6 monoclonal antibody with better side effects profile for the treatment of psoriasis [Corrigendum] |
title | Itolizumab – a humanized anti-CD6 monoclonal antibody with better side effects profile for the treatment of psoriasis [Corrigendum] |
title_full | Itolizumab – a humanized anti-CD6 monoclonal antibody with better side effects profile for the treatment of psoriasis [Corrigendum] |
title_fullStr | Itolizumab – a humanized anti-CD6 monoclonal antibody with better side effects profile for the treatment of psoriasis [Corrigendum] |
title_full_unstemmed | Itolizumab – a humanized anti-CD6 monoclonal antibody with better side effects profile for the treatment of psoriasis [Corrigendum] |
title_short | Itolizumab – a humanized anti-CD6 monoclonal antibody with better side effects profile for the treatment of psoriasis [Corrigendum] |
title_sort | itolizumab – a humanized anti-cd6 monoclonal antibody with better side effects profile for the treatment of psoriasis [corrigendum] |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461136/ https://www.ncbi.nlm.nih.gov/pubmed/26082656 http://dx.doi.org/10.2147/CCID.S88448 |